HOB Biotech Group Corp.,Ltd

SHSE:688656 Stock Report

Market Cap: CN¥8.5b

HOB Biotech GroupLtd Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for HOB Biotech GroupLtd.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Biotechs earnings growth43.4%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

No updates

Recent updates

HOB Biotech GroupLtd's (SHSE:688656) Anemic Earnings Might Be Worse Than You Think

Nov 04
HOB Biotech GroupLtd's (SHSE:688656) Anemic Earnings Might Be Worse Than You Think

Earnings Not Telling The Story For HOB Biotech Group Corp.,Ltd (SHSE:688656) After Shares Rise 43%

Oct 08
Earnings Not Telling The Story For HOB Biotech Group Corp.,Ltd (SHSE:688656) After Shares Rise 43%

Subdued Growth No Barrier To HOB Biotech Group Corp.,Ltd's (SHSE:688656) Price

Jul 04
Subdued Growth No Barrier To HOB Biotech Group Corp.,Ltd's (SHSE:688656) Price

HOB Biotech GroupLtd's (SHSE:688656) Earnings Are Weaker Than They Seem

May 06
HOB Biotech GroupLtd's (SHSE:688656) Earnings Are Weaker Than They Seem

Earnings Not Telling The Story For HOB Biotech Group Corp.,Ltd (SHSE:688656) After Shares Rise 25%

Mar 08
Earnings Not Telling The Story For HOB Biotech Group Corp.,Ltd (SHSE:688656) After Shares Rise 25%

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as HOB Biotech GroupLtd has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

SHSE:688656 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
9/30/202440135-75107N/A
6/30/202440746-98105N/A
3/31/202439946-98108N/A
12/31/202339447-75103N/A
9/30/202336636-8686N/A
6/30/202336039-10672N/A
3/31/202332534-15057N/A
12/31/202232042-16258N/A
9/30/202233656-145104N/A
6/30/202232165-13299N/A
3/31/202233386-97101N/A
12/31/202131886-63105N/A
9/30/202131493-4174N/A
6/30/202129183-1879N/A
3/31/202126275-1276N/A
12/31/202022257158N/A
9/30/2020206481454N/A
12/31/2019259643469N/A
12/31/2018201402047N/A
12/31/201714621N/A22N/A
12/31/20161124N/A6N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if 688656's forecast earnings growth is above the savings rate (2.8%).

Earnings vs Market: Insufficient data to determine if 688656's earnings are forecast to grow faster than the CN market

High Growth Earnings: Insufficient data to determine if 688656's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if 688656's revenue is forecast to grow faster than the CN market.

High Growth Revenue: Insufficient data to determine if 688656's revenue is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if 688656's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y